MM

Maryann Marino

Maryann Marino


Experienced Finance Director with a Proven Track Record in the Pharmaceutical Industry



Professional Overview
Maryann Marino is an accomplished Finance Director with extensive experience in the pharmaceutical industry. She possesses a strong background in financial management, strategic planning, and business operations, leveraging her expertise to drive organizational success.

Experience Summary

Current Role
As the Director of Finance at Eisai US, Maryann is responsible for overseeing the company's financial operations, including budgeting, forecasting, and financial reporting. She plays a crucial role in aligning financial strategies with Eisai's business objectives, ensuring efficient resource allocation and financial optimization.

Career Progression
Maryann's career journey in the finance sector spans over 15 years. Prior to her current role, she served as the Associate Director of Finance at Eisai US, where she successfully implemented process improvements and streamlined financial reporting, contributing to the company's overall financial performance. Earlier in her career, Maryann held positions as a Senior Manager of Finance at Eisai US, as well as an Auditor at Deloitte and a Financial Analyst at Bristol-Myers Squibb (BMS).

Academic Background
Maryann holds a Bachelor of Science degree in Accounting from the University of Delaware, where she graduated with honors. Her strong academic foundation has provided her with a solid understanding of financial principles and best practices.

Areas of Expertise
  • Financial management and strategy

  • Financial planning and analysis

  • Budgeting and forecasting

  • Financial reporting and compliance

  • Process improvement and operational efficiency

  • Cross-functional collaboration and team leadership


Professional Impact
During her tenure at Eisai US, Maryann has played a pivotal role in driving financial initiatives that have significantly improved the company's bottom line. She spearheaded the implementation of a new financial reporting system, resulting in enhanced data accuracy and faster decision-making. Additionally, Maryann's leadership in streamlining the budgeting process has contributed to more effective resource allocation and cost savings.

Conclusion
Maryann Marino's extensive experience, financial expertise, and strategic mindset make her a valuable asset to the Eisai US team. Her commitment to driving financial excellence and aligning financial strategies with business objectives positions her as a trusted finance professional in the pharmaceutical industry.